Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kasper Fjellhaugen Hjuler

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Ugeskrift for Laeger|November 4, 2016
[Mountain medicine. II]Bjørn Bay, Kasper Fjellhaugen Hjuler
Ugeskrift for Laeger|November 4, 2016
[Mountain medicine - an introduction. I]Kasper Fjellhaugen Hjuler, Bjørn Bay
Dermatology (Basel, Switzerland)|December 21, 2013
Melanoma associated with the use of melanotan-IIKasper Fjellhaugen Hjuler, Henrik Frank Lorentzen
Psoriasis (Auckland, N.Z.)|June 17, 2022
Comorbidity in Adult Psoriasis: Considerations for the ClinicianChristine Daugaard, Lars Iversen, Kasper Fjellhaugen Hjuler
The Journal of Dermatological Treatment|October 6, 2022
Guselkumab, tildrakizumab, and risankizumab in a real-world setting: drug survival and effectiveness in the treatment of psoriasis and psoriatic arthritisCathrine Dawn Büttner Elgaard, Lars Iversen, Kasper Fjellhaugen Hjuler
Drugs in R&D|May 8, 2023
Single-Centre Real-World Study on Drug Survival and Effectiveness of Brodalumab for Treatment of Psoriasis and Psoriatic ArthritisCathrine Dawn Büttner Elgaard, Lars Iversen, Kasper Fjellhaugen Hjuler
Dermatology (Basel, Switzerland)|March 15, 2023
Arthritis Hit Rate in Patients with Psoriasis Referred for Rheumatology EvaluationCatalina Hartmann Skovsgård, Trine Bay Laurberg, Anders Dige, et al.
Annals of the Rheumatic Diseases|October 27, 2020
Brodalumab in psoriatic arthritis: results from the randomised phase III AMVISION-1 and AMVISION-2 trialsPhilip J Mease, Philip S Helliwell, Kasper Fjellhaugen Hjuler, et al.
JAMA Dermatology|July 8, 2016
Association Between Changes in Coronary Artery Disease Progression and Treatment With Biologic Agents for Severe PsoriasisKasper Fjellhaugen Hjuler, Morten Bøttcher, Christian Vestergaard, et al.
Biomolecules|November 27, 2025
Observing Picomolar Protein Unfolding Using Resonance Light ScatteringAlain Bolaño Alvarez, Kristian Bakke Arvesen, Kasper Fjellhaugen Hjuler, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Ugeskrift for Laeger|November 4, 2016
[Mountain medicine. II]Bjørn Bay, Kasper Fjellhaugen Hjuler
Ugeskrift for Laeger|November 4, 2016
[Mountain medicine - an introduction. I]Kasper Fjellhaugen Hjuler, Bjørn Bay
Dermatology (Basel, Switzerland)|December 21, 2013
Melanoma associated with the use of melanotan-IIKasper Fjellhaugen Hjuler, Henrik Frank Lorentzen
Psoriasis (Auckland, N.Z.)|June 17, 2022
Comorbidity in Adult Psoriasis: Considerations for the ClinicianChristine Daugaard, Lars Iversen, Kasper Fjellhaugen Hjuler
The Journal of Dermatological Treatment|October 6, 2022
Guselkumab, tildrakizumab, and risankizumab in a real-world setting: drug survival and effectiveness in the treatment of psoriasis and psoriatic arthritisCathrine Dawn Büttner Elgaard, Lars Iversen, Kasper Fjellhaugen Hjuler
Drugs in R&D|May 8, 2023
Single-Centre Real-World Study on Drug Survival and Effectiveness of Brodalumab for Treatment of Psoriasis and Psoriatic ArthritisCathrine Dawn Büttner Elgaard, Lars Iversen, Kasper Fjellhaugen Hjuler
Dermatology (Basel, Switzerland)|March 15, 2023
Arthritis Hit Rate in Patients with Psoriasis Referred for Rheumatology EvaluationCatalina Hartmann Skovsgård, Trine Bay Laurberg, Anders Dige, et al.
Annals of the Rheumatic Diseases|October 27, 2020
Brodalumab in psoriatic arthritis: results from the randomised phase III AMVISION-1 and AMVISION-2 trialsPhilip J Mease, Philip S Helliwell, Kasper Fjellhaugen Hjuler, et al.
JAMA Dermatology|July 8, 2016
Association Between Changes in Coronary Artery Disease Progression and Treatment With Biologic Agents for Severe PsoriasisKasper Fjellhaugen Hjuler, Morten Bøttcher, Christian Vestergaard, et al.
Biomolecules|November 27, 2025
Observing Picomolar Protein Unfolding Using Resonance Light ScatteringAlain Bolaño Alvarez, Kristian Bakke Arvesen, Kasper Fjellhaugen Hjuler, et al.
Pageof 2